BMSSC
DGX icon

B. Metzler seel. Sohn & Co’s Quest Diagnostics DGX Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.17M Buy
10,247
+321
+3% +$63K 0.02% 405
2026
Q1 		$1.95M Buy
9,926
+1,890
+24% +$367K 0.02% 391
2025
Q4 		$1.39M Buy
8,036
+1,305
+19% +$238K 0.01% 480
2025
Q3 		$1.28M Sell
6,731
-1,563
-19% -$277K 0.01% 496
2025
Q2 		$1.49M Buy
8,294
+594
+8% +$103K 0.01% 447
2025
Q1 		$1.3M Buy
7,700
+1,369
+22% +$225K 0.01% 454
2024
Q4 		$955K Sell
6,331
-618
-9% -$96.1K 0.01% 549
2024
Q3 		$1.08M Hold
6,949
– – 0.01% 532
2024
Q2 		$951K Sell
6,949
-1,046
-13% -$143K 0.01% 536
2024
Q1 		$1.06M Sell
7,995
-14,647
-65% -$1.9M 0.01% 514
2023
Q4 		$3.12M Sell
22,642
-4,195
-16% -$552K 0.04% 263
2023
Q3 		$3.27M Buy
26,837
+3,207
+14% +$427K 0.05% 222
2023
Q2 		$3.32M Hold
23,630
– – 0.05% 278
2023
Q1 		$3.34M Buy
23,630
+333
+1% +$47.6K 0.05% 206
2022
Q4 		$3.64M Buy
23,297
+3,066
+15% +$441K 0.06% 195
2022
Q3 		$2.48M Sell
20,231
-4,333
-18% -$571K 0.05% 242
2022
Q2 		$3.27M Sell
24,564
-3,662
-13% -$499K 0.05% 215
2022
Q1 		$3.86M Buy
28,226
+4,180
+17% +$583K 0.05% 217
2021
Q4 		$4.12M Sell
24,046
-1,617
-6% -$246K 0.05% 218
2021
Q3 		$3.73M Buy
25,663
+8,970
+54% +$1.31M 0.05% 207
2021
Q2 		$2.2M Sell
16,693
-3,556
-18% -$466K 0.03% 282
2021
Q1 		$2.6M Buy
20,249
+4,162
+26% +$513K 0.04% 246
2020
Q4 		$1.95M Buy
+16,087
New +$1.96M 0.04% 277

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

B. Metzler seel. Sohn & Co's DGX Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its Quest Diagnostics (DGX) stake by 3.2% in Q2 2026, buying an estimated $63K and bringing the position to 10,247 shares worth $2.17M. The position accounts for 0.02% of the portfolio, ranked #405.

B. Metzler seel. Sohn & Co first reported a position in DGX in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.12M in Q4 2021. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 10,247 shares of Quest Diagnostics worth $2.17M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 321 Quest Diagnostics shares in Q2 2026, an estimated $63K.
  • Quest Diagnostics made up 0.02% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #405 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Quest Diagnostics in Q4 2020 and has held it in 23 quarters since.
  • B. Metzler seel. Sohn & Co's Quest Diagnostics position peaked at $4.12M in Q4 2021.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.